SEARCH

SEARCH BY CITATION

References

  • 1
    Andree, H., Reutelingsperger, C., Hauptmann, R., Hemker, H., Hermens, W. & Willems, G. (1990) Binding of vascular anticoagulant a (VACa) to planar phospholipid bilayers. Journal of Biological Chemistry, 265, 49234928.
  • 2
    Boccadoro, M., Gavarotti, P., Fossati, G., Pileri, A., Marmont, F., Neretto, G., Gallamini, A., Volta, C., Tribalto, M., Testa, M., Amadori, S., Mandelli, F. & Durie, B. (1984) Low plasma cell [3H]thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. British Journal of Haematology, 58, 689.
  • 3
    Durie, B., Salmon, S. & Moon, T. (1980) Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood, 55, 364372.
  • 4
    Ffrench, M., Ffrench, P., Remy, F., Chapuis-Cellier, C., Wolowiec, D., Ville, D. & Bryon, P. (1995) Plasma cell proliferation in monoclonal gammopathy: relations with other biologic variables — diagnostic and prognostic significance. American Journal of Medicine, 98, 6066.DOI: 10.1016/S0002-9343(99)80081-3
  • 5
    Georgii-Hemming, P., Wiklund, H.J., Ljunggren, O. & Nilsson, K. (1996) Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood, 88, 22502258.
  • 6
    Greipp, P., Katzmann, J., O'Fallon, W. & Kyle, R. (1988) Value of β2 microglobulin level and plasma cell labelling indices as prognostic factors in patients with newly diagnosed myeloma. Blood, 72, 219223.
  • 7
    Greipp, P., , Lust, J., O'Fallon, M., Katzmann, J., Witzig, T. & Kyle, R. (1993) Plasma cell labelling index and β2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood, 81, 33823387.
  • 8
    Greipp, P., Witzig, T. & Gonchoroff, N. (1985) Immunofluorescent plasma cell labelling indices using a monoclonal antibody (BU-1). American Journal of Hematology, 20, 289292.
  • 9
    Jelinek, D.F., Witzig, T.E. & Arendt, B.K. (1997) A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth. Journal of Immunology, 159, 487496.
  • 10
    Joshua, D., Ioannidis, R., Brown, R., Francis, S., Gibson, J. & Kronenberg, H. (1988) Multiple myeloma: relationship between light chain isotype suppression, labelling index of plasma cells and CD38 expression on peripheral blood lymphocytes. American Journal of Hematology, 29, 511.
  • 11
    Kasagi, N., Gomyo, Y., Shirai, H., Tsujitani, S. & Ito, H. (1994) Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling. Japanese Journal of Cancer Research, 85, 939945.
  • 12
    King, E., Matteson, J., Jacobs, S. & Kyprianou, N. (1996) Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumour progression. Journal of Urology, 155, 316320.DOI: 10.1097/00005392-199601000-00131
  • 13
    Klein, B., Zhang, X.-G., Lu, Z.-Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863872.
  • 14
    Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S. & Van Oers, M. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 14151420.
  • 15
    Krajewski, S., Gascoyne, R.D., Zapata, J.M., Krajewska, M., Kitada, S., Chhanabhai, M., Horsman, D., Berean, K., Piro, L.D., Fugiervivier, I., Liu, Y.J., Wang, H.G. & Reed, J.C. (1997) Immunolocalization of the ice/Ced-3-family protease, Cpp32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood, 89, 38173825.
  • 16
    Lichtenstein, A., Berenson, J., Norman, D., Chang, M.-P. & Carlile, A. (1989) Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood, 74, 12661273.
  • 17
    Lichtenstein, A., Tu, Y., Fady, C., Vescio, R. & Berenson, J. (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cellular Immunology, 162, 248255.DOI: 10.1006/cimm.1995.1076
  • 18
    Lu, C. & Tanigawa, N. (1997) Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Research, 57, 221224.
  • 19
    McGahon, A., Martin, S., Bissonnette, R., Mahboubi, A., Shi, Y., Mogil, R., Nishioka, W. & Green, D. (1995) The end of the (cell) line: methods for the study of apoptosis in vitro. Methods in Cell Biology, 46, 153185.
  • 20
    Ogata, A., Chauhan, D., Teoh, G., Treon, S.P., Urashima, M., Schlossman, R.L. & Anderson, K.C. (1997) IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. Journal of Immunology, 159, 22122221.
  • 21
    Philpott, N., Scopes, J., Marsh, J., Gordon-Smith, E. & Gibson, F. (1995) Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Experimental Hematology, 23, 16421648.
  • 22
    Philpott, N., Turner, A., Scopes, J., Westby, M., Marsh, J., Gordon-Smith, E., Dalgleish, A. & Gibson, F. (1996) The use of 7-aminoactinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood, 87, 22442251.
  • 23
    Rawstron, A.C., Owen, R.G., Davies, F.E., Johnson, R.J., Jones, R.A., Richards, S.J., Evans, P.A., Child, J.A., Smith, G.M., Jack, A.S. & Morgan, G.J. (1997) Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. British Journal of Haematology, 97, 4655.DOI: 10.1046/j.1365-2141.1997.72653.x
  • 24
    San Miguel, J., García-Sanz, R., González, M., Moro, M., Hernández, J., Ortega, F., Borrego, D., Carnero, M., Casanova, F., Jiménez, R., Portero, J. & Orfao, A. (1995) A new staging system for multiple myeloma based on the number of S-phase plasma cells. Blood, 85, 448455.
  • 25
    Schneider, U., Van Lessen, A., Huhn, D. & Serke, S. (1997) Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. British Journal of Haematology, 97, 5664.DOI: 10.1046/j.1365-2141.1997.d01-2115.x
  • 26
    Schwarze, M. & Hawley, R. (1995) Prevention of myeloma cell apoptosis by ectopic bcl-2 expression of interleukin 6-mediated up-regulation of bcl-xL. Cancer Research, 55, 22622265.
  • 27
    Spets, H., Jernberg-Wiklund, H., Sambade, C., Soderberg, O. & Nilsson, K. (1997) The effects on growth and survival of IL-6 can be dissociated in the U-266-1970/U-266-1984 and HL407E/HL407L human multiple myeloma cell lines. British Journal of Haematology, 98, 126133.DOI: 10.1046/j.1365-2141.1997.1903004.x
  • 28
    Steck, K., McDonnell, T., Sneige, N. & El-Naggar, A. (1996) Flow cytometric analysis of apoptosis and BCL-2 in primary breast carcinomas: clinical and biological implications. Cytometry, 24, 116122.
  • 29
    Teoh, G., Urashima, M., Ogata, A., Chauhan, D., Decaprio, J.A., Treon, S.P., Schlossman, R.L. & Anderson, K.C. (1997) Mdm2 protein overexpression promotes proliferation and survival of multiple myeloma cells. Blood, 90, 19821992.
  • 30
    Urashima, M., Teoh, G., Chauhan, D., Hoshi, Y., Ogata, A., Treon, S.P., Schlossman, R.L. & Anderson, K.C. (1997) Interleukin-6 overcomes P21 Waf1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells. Blood, 90, 279289.
  • 31
    Westendorf, J., Ahmann, G., Armitage, R., Spriggs, M., Lust, J., Greipp, P., Katzmann, J. & Jelinek, D. (1994) CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. Journal of Immunology, 152, 117128.
  • 32
    Westendorf, J., Ahmann, G., Greipp, P., Witzig, T., Lust, J. & Jelinek, D. (1996) Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia, 10, 866876.
  • 33
    Witzig, T., Gertz, M., Lust, J., Kyle, R., O'Fallon, W. & Greipp, P. (1996a) Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood, 88, 17801787.
  • 34
    Witzig, T., Kimlinger, T., Ahmann, G., Katzmann, J. & Greipp, P. (1996b) Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry, 26, 113120.
  • 35
    Xu, F., Gardner, A., Tu, Y., Michl, P., Prager, D. & Lichtenstein, A. (1997) Multiple myeloma cells are protected against dexamethasone-induced apoptosis by insulin-like growth factors. British Journal of Haematology, 97, 429440.DOI: 10.1046/j.1365-2141.1997.592708.x